132 related articles for article (PubMed ID: 20380096)
21. Topical treatment for bacterial vaginosis.
Med Lett Drugs Ther; 1992 Nov; 34(884):109. PubMed ID: 1435507
[No Abstract] [Full Text] [Related]
22. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.
Mastromarino P; Macchia S; Meggiorini L; Trinchieri V; Mosca L; Perluigi M; Midulla C
Clin Microbiol Infect; 2009 Jan; 15(1):67-74. PubMed ID: 19046169
[TBL] [Abstract][Full Text] [Related]
23. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.
Rosenstein IJ; Morgan DJ; Lamont RF; Sheehan M; Doré CJ; Hay PE; Taylor-Robinson D
Infect Dis Obstet Gynecol; 2000; 8(3-4):158-65. PubMed ID: 10968599
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.
Sobel J; Peipert JF; McGregor JA; Livengood C; Martin M; Robbins J; Wajszczuk CP
Infect Dis Obstet Gynecol; 2001; 9(1):9-15. PubMed ID: 11368263
[TBL] [Abstract][Full Text] [Related]
25. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
[TBL] [Abstract][Full Text] [Related]
26. Fulminant pseudomembranous colitis caused by clindamycin phosphate vaginal cream.
Trexler MF; Fraser TG; Jones MP
Am J Gastroenterol; 1997 Nov; 92(11):2112-3. PubMed ID: 9362204
[No Abstract] [Full Text] [Related]
27. Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathogens.
Atassi F; Servin AL
FEMS Microbiol Lett; 2010 Mar; 304(1):29-38. PubMed ID: 20082639
[TBL] [Abstract][Full Text] [Related]
28. Probiotic strategies for the treatment and prevention of bacterial vaginosis.
MacPhee RA; Hummelen R; Bisanz JE; Miller WL; Reid G
Expert Opin Pharmacother; 2010 Dec; 11(18):2985-95. PubMed ID: 21080853
[TBL] [Abstract][Full Text] [Related]
29. [Bacterial vaginosis. Relation between the vaginal flora and the vaginal epithelial cells under different treatments. Ultrastructural study].
Flores Rivera E; Casanova Roman G; Beltrán M; González Jimenez MA; Villegas Castrejon H
Ginecol Obstet Mex; 1997 May; 65():182-90. PubMed ID: 9273327
[TBL] [Abstract][Full Text] [Related]
30. Pilot randomized trial for treatment of bacterial vaginosis using in situ forming metronidazole vaginal gel.
Shaaban OM; Fetih GN; Abdellah NH; Ismail S; Ibrahim MA; Ibrahim el-SA
J Obstet Gynaecol Res; 2011 Jul; 37(7):874-81. PubMed ID: 21410839
[TBL] [Abstract][Full Text] [Related]
31. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.
Schmitt C; Sobel JD; Meriwether C
Obstet Gynecol; 1992 Jun; 79(6):1020-3. PubMed ID: 1579299
[TBL] [Abstract][Full Text] [Related]
32. Fertility intentions of HIV-1 infected and uninfected women in Malawi: a longitudinal study.
Taulo F; Berry M; Tsui A; Makanani B; Kafulafula G; Li Q; Nkhoma C; Kumwenda JJ; Kumwenda N; Taha TE
AIDS Behav; 2009 Jun; 13 Suppl 1():20-7. PubMed ID: 19308718
[TBL] [Abstract][Full Text] [Related]
33. [Vaginal microflora and vagini].
Shi YF
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):3-5. PubMed ID: 19563052
[No Abstract] [Full Text] [Related]
34. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of bacterial vaginosis with a policarbophil-carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial.
Fiorilli A; Molteni B; Milani M
Eur J Obstet Gynecol Reprod Biol; 2005 Jun; 120(2):202-5. PubMed ID: 15925053
[TBL] [Abstract][Full Text] [Related]
36. [Vaginal ecosystem].
Karag'ozov I; Shopova E; Andreeva P
Akush Ginekol (Sofiia); 2004; 43 Suppl 3():34-9. PubMed ID: 15673027
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota.
Cruciani F; Brigidi P; Calanni F; Lauro V; Tacchi R; Donders G; Peters K; Guaschino S; Vitali B
Antimicrob Agents Chemother; 2012 Aug; 56(8):4062-70. PubMed ID: 22585228
[TBL] [Abstract][Full Text] [Related]
38. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study.
Larsson PG; Platz-Christensen JJ; Dalaker K; Eriksson K; Fåhraeus L; Irminger K; Jerve F; Stray-Pedersen B; Wölner-Hanssen P
Acta Obstet Gynecol Scand; 2000 May; 79(5):390-6. PubMed ID: 10830767
[TBL] [Abstract][Full Text] [Related]
39. Study reports vaginal gel can help improve reversion to normal pap smear.
Oncology (Williston Park); 1996 Feb; 10(2):218, 221. PubMed ID: 8838264
[No Abstract] [Full Text] [Related]
40. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.
Sobel JD; Ferris D; Schwebke J; Nyirjesy P; Wiesenfeld HC; Peipert J; Soper D; Ohmit SE; Hillier SL
Am J Obstet Gynecol; 2006 May; 194(5):1283-9. PubMed ID: 16647911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
